Viewing nowCombinationEmpogaduo Tablet 12.5/1000 Milligrams (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 202302783 · Approved 2023.09.20 · Insurance code 651206250
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adults with type 2 diabetes in conjunction with diet and exercise. It particularly helps with blood sugar management in patients with cardiovascular disease and it is important to administer it safely by referring to clinical trial information from professionals. Therefore, this medication is used as a treatment to assist with blood sugar control and prevention of cardiovascular events.
The recommended dose of this medicine is 1 tablet per dose, twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive the same doses of empagliflozin and metformin they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, treatment should be initiated with the individual components, empagliflozin and metformin, because the starting dose of metformin is 500 mg or 850 mg once daily. The maximum daily dose of metformin hydrochloride that can be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication assists in controlling blood sugar levels and is used in diabetes treatment. There is a risk of a rare but serious side effect called lactic acidosis, which may occur during the use of this medicine. Lactic acidosis happens when there is an excessive buildup of lactic acid in the body, with symptoms such as muscle pain, trouble breathing, abdominal pain, and fatigue. This medication should not be administered to patients with impaired kidney function, and it is important to regularly check for any decline in kidney function. The use of this medication should be temporarily suspended during conditions such as acute infection, dehydration, cardiac issues, or around the time of surgery; it can be resumed once the condition stabilizes. When taken together with other diabetes medications such as insulin or sulfonylureas, the risk of hypoglycemia may increase, so blood sugar levels need to be monitored closely and medication doses adjusted as necessary. This medication may increase the risk of urinary tract infections or genital infections; thus, immediate consultation with a doctor is necessary if infection symptoms appear. Moreover, in cases of fluid depletion, low blood pressure or dehydration may occur, so if there are symptoms of dehydration, diarrhea, or vomiting, it is advised to stop taking this medication and consult healthcare personnel. Pregnant or breastfeeding women should not use this medication, and it is not recommended for children under the age of 18. Severe side effects may occur from overdose, so doses should be strictly adhered to, and if unusual symptoms develop, a hospital visit is necessary. Regular blood tests to check kidney function and vitamin B12 levels are important during the use of this medication. Alcohol can increase the risk of side effects, so it is recommended to avoid drinking during treatment. Finally, this medication should be kept out of reach of children and stored in its original container to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a well-sealed container to prevent exposure to air or moisture. The recommended storage temperature is room temperature between 1°C and 30°C.
A dark brown, purplish, oval-shaped, bi-convex, film-coated tablet
For domestic use - 60 tablets/bottle, For domestic use - 30 tablets/bottle, For domestic use - 10 tablets/box [(10 tablets/PTPx1)], For domestic use - 60 tablets/box [(10 tablets/PTPx6)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.